We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Beckman Selects Fisher Unit, Cellomics, to Provide Ongoing Service for HCS Customers
News

Beckman Selects Fisher Unit, Cellomics, to Provide Ongoing Service for HCS Customers

Beckman Selects Fisher Unit, Cellomics, to Provide Ongoing Service for HCS Customers
News

Beckman Selects Fisher Unit, Cellomics, to Provide Ongoing Service for HCS Customers

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Beckman Selects Fisher Unit, Cellomics, to Provide Ongoing Service for HCS Customers"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Cellomics, unit of Fisher Biosciences, has announced that it has reached an agreement to provide maintenance and service support to HCS customers of Beckman Coulter Inc.

This agreement covers the Beckman Coulter Cell Lab IC 100 Image Cytometer and the EIDAQ 100 High-Throughput Microscopy System.

Beckman Coulter recently announced that it would no longer market these products but would continue to support existing customers.
 
"Our primary goal in reaching this agreement was to provide ongoing support for our customers," said Karen Bezold, director of Research Cytometry, Beckman Coulter, Inc.

"With Cellomics’ expertise in the HCS field, we are confident our customers will have the best possible support going forward."

Beckman Coulter will continue to focus its research cytometry business on flow cytometry and particle characterization.
 
"Our agreement with Beckman Coulter is an affirmation of Cellomics’ technology leadership and service excellence," said Ron Lowy, president and chief executive officer of Fisher Biosciences.

"We have the expertise to answer virtually any question concerning HCS and help customers solve any technical problems they may encounter."

"We are excited about the opportunity to serve another group of customers who are interested in HCS technology."

Advertisement